Introduction
============

Anandamide (AEA) is an endocannabinoid operative in several biological functions. Nevertheless, it is not known the effect of aerobic exercise training (EXT) on plasma \[AEA\].

Aims
====

Because a dysfunctional endocannabinoid system has been suggested to underlie migraine (M) pathophysiology, we intended to explore the plasma \[AEA\] after EXT in M patients and healthy individuals.

Methods
=======

EXT protocol consisted of 12-week of supervised treadmill at standardized intensity, performed 3 times/week, 30 min./session. Four groups were separated for intervention or waiting list: Healthy subjects without AET (CC), healthy subjects undergoing EXT (CEXE), M patients without EXT (MC), and M patients undergoing EXT (MEXE). Patients had episodic migraine with and without aura (ICHDII). Blood collections were performed interictally at least 24h after attacks or anti-inflammatory use. AEA was quantified by LC/MS/MS. All participants took no preventive medication.

Results
=======

The study included 48 participants (12 for each group) and groups matched by age, sex, and BMI. Baseline \[AEA\] was not different between groups. AEA reduced in MEXE and CEXE, but was statistically significant only in CEXE (p = 0.007). There was a trend to a negative correlation between adherence and ΔAEA (r=-0.565, p = 0.056).

Conclusions
===========

Plasma AEA decreases after EXT in healthy subjects. In M patients, this response is prevented by lower adherence. Future studies should investigate the relationship between exercise-reward and AEA.

\* p = 0.007, Friedman´s Test
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